Valcare Medical

Developer of minimally-invasive technologies for mitral regurgitation treatment and repair

placeHerzliya, Tel Aviv, Israel calendar_todayFounded 2012 groups30 employees language valcaremedical.com

Innovation

14 patent families (7 granted) — focus: Human necessities; filing pace active. Cited 1,707 times.

YearFilings
20247
202511
20263

Investor mix

5 investors on record; lead investors include Accelmed Ventures; 1 has since exited.

Investor typeCountShare
Venture capital360%
Private equity240%
Coming soon